Stock Events

Acadia Pharmaceuticals (ACAD) Q3 2013 Earnings

6AugConfirmed
Nov 12
Mar 13
May 13
Q3 2013
-0.11
-0.09
-0.06
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.11
Surprise EPS
-0.11
Surprise Percent
+∞%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.11 per share for Q3 2013.

0 Comments

Share your thoughts